In this context, researchers have identified a novel transcriptional mechanism that regulates ATP7B expression in drug-resistant tumor cells through Pt-dependent transcription factor EB (TFEB) activation (Petruzzelli et al., 2022). The gene discussed is TFEB; the disease is neoplasm.